Is Bio Key International going out of business?

BIO KEY INTERNATIONAL INC (BKYI) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

BIO KEY INTERNATIONAL INC (BKYI) scores 28 out of 100 on fundamentals, Distressed / Caution, based on SEC filing data.

Leading signal: FCF margin: -78.83%

Five questions, kept separate

Survival - Critical

3-5 mo of estimated runway from 2026-06-30, based on $1.4M of cash and short-term investments against $4.7M of annual burn.

Business quality - Poor

-115.0% operating margin and -78.8% FCF margin produce a poor Business Quality assessment.

Trajectory - Contracting

Revenue weakened 3.1%; operating margin weakened 34.7pp; FCF margin weakened 13.5pp. The TTM window includes a mixed-basis Q4 estimate.

Valuation - Extreme expectations

-106.1% FCF yield supports an extreme expectations Valuation assessment on the annual basis.

Event risk - Evidence unavailable

No active asserted adverse event was found in the available filing evidence. The filing evidence is stale or incomplete, so this is not proof of absence.

What the rules read

• FCF margin: -78.83%
• Gross margin: 76.88%
• Debt / Equity: -0.28x (Net Cash)
• ROE quality: -165.12%
• ROIC: -235.77%
• Net income trend: 50.59% (Loss narrowing)
• Asset Efficiency: 0.79x
• R&D intensity: 32.69%
• Revenue growth YoY: 13.15% (YoY)
• Return on Assets: -95.66%
• Cash Burn Deceleration: -275.74% QoQ improvement (Worsening)
• Revenue Quality: Quality concerns (DSO +54d, Rev +13%)

Read from filings through 2026-08-13.

Price as of 2026-08-22.